Barry et al. (1987), "Withdrawal Syndrome Following Subchronic Treatment with Anxiolytic Agents", Pharmac. Biochem. Behav., vol. 27, pp. 239-245. |
B.o slashed.ges.o slashed., K. P. et al. (1985), "3-Phenyl-1-indanamines. Potential Antidepressant Activity and Potent Inhibition of Dopamine, Norepinephrine, and Serotonin Uptake", J. Med. Chem., vol. 28, pp.1817-1828. |
B.o slashed.ges.o slashed., K. P. et al. (1988), "Antihypertensive Activity in a Series of 1-Piperazino-3-phenylindans with Potent 5-HT.sub.2 -Antagonostic Activity", J. Med. Chem., vol. 31, pp. 2247-2256. |
B.o slashed.ges.o slashed., K. P. (1983), "Neuroleptic Activity an Dopamine-Uptake Inhibition in 1-Piperazino-3-phenylindans", J. Med. Chem., vol. 26, pp. 935-947. |
Hyttel, J. et al. (1985), "Neurochemical Profile of Lu 19-005, a Potent Inhibitor of Uptake of Dopamine, Noradrenaline, and Serotonin", J. Neurochem., vol. 44, pp. 1615-1622. |
Sommer, M. B. et al. (1990), "Application of (2-Cyanoaryl) Arylacetonitriles in Cyclization of Annulation Reactions. Preparation of 3-Arylindans, 4-Aryl-3,4-Dihydronaphthalenes, 4-Arylisoquinolines, 1-Aminonaphtalenes, and Heterocyclic Anaolgues", J. Org. Chem., vol. 55, pp. 4822-4827. |
Perregaard et al. (1992), "Noncataleptogenic, Centrally Acting Dopamine D-2 and Serotonin 5-HT.sub.2 Antagonists within a Series of 3-Substituted 1-(4-Flurophenyl)-1H-Indoles", J. Med. Chem., vol. 35, pp. 1092-1101. |
Martin et al. (1989), "Activity of Aromatic Substituted Phenylpiperazines Lacking Affinity for Dopamine Binding Sites in a Preclinical Test of Antipsychotic Efficacy", J. Med. Chem., vol. 32, pp. 1052-1056. |
McMillen, B. A. et al. (1988), "N-Alkyl-Substituted Aryl-Piperazine Drugs: Relationship Between Affinity for Serotonin Receptors and Inhabition of Aggression", Drug Develop. Res., vol. 12, pp. 53-62. |
Rao, T. S. et al. (1990), "Inhibition of Climbing and Mossy Fiber, and Basket and Stellate Cell Inputs to Mouse Cerebellar Purkinje Cells by Novel Anti-Ischemic Agents, Ifenprodil and BMY-14802", Life Sciences, vol. 47, pp. PL-1-PL-5. |
Sanchez et al. (1991) , "Neurochemical and In Vivo Pharmacological Profile of Sertindole, a Limbic-Selective, Neuroleptic Compound", Drug Deve. Res., vol. 22, pp. 239-250. |
Schwiezer, E. et al. (1986), "Failure of Buspirone to Manage Benzodiazephine Withdrawal", Am. J. Psychiat., vol. 143, No. 12, pp. 1590-1592. |
Skarsfeldt, T. et al. (1990), "Sertindole, A New Neuroleptic with Extreme Selectivity on A10 Versus A9 Dopamine Neurones in the Rat", Eur. J. Pharmacol., vol. 182, pp. 613-614. |
K. B.o slashed.ges.o slashed. et al. J.Med. Chem., 38 p. 4380 (1995). |
P.T. Martin et al., Schizophrenia Research, vol. 11, p. 107, (1994). |
K. P. B.o slashed.ges.o slashed. et al., J. Med. Chem., vol. 36, pp. 2761-2770, (1993). |
J. Hyttel et al., Clinical Pharm. in Psychiatry, pp. 109-122, (1989). |
J. Arnt et al., Drug Develop. Res., vol. 16, pp. 59-70, (1989). |
J. Hyttel et al., Drug Dev. Res. 15, 389-404 (1988). |
LeFur, G. et al., Biochem. Parmacol., vol. 26, pp. 497-503 (1977). |